MONALISA ULTRA TYPE 1x1 ml
Monalisa Ultra Type is a high-performance hyaluronic acid dermal filler developed by Genoss Co., Ltd. (South Korea) for deep wrinkle correction and significant volume restoration.
Using advanced HY-BRID cross-linking technology, it provides exceptional firmness, elasticity, and lifting capacity, ensuring long-lasting, natural-looking facial enhancement and contour definition.
Product Overview
Monalisa Ultra Type is specifically engineered for patients seeking durable volume and structure in areas that require deeper correction.
Its dense, cohesive formulation delivers powerful lifting effects, ideal for reshaping facial contours and treating pronounced wrinkles while maintaining a natural tissue feel and smooth integration.
Composition & Technology
Hyaluronic Acid: 24 mg/ml, non-animal origin, highly purified for optimal safety and biocompatibility.
Lidocaine: 0.3% for a comfortable and virtually pain-free injection experience.
HY-BRID Cross-Linking Technology: Exclusive Genoss process combining high and low molecular weight HA for superior cross-linking stability, providing both elasticity and longevity.
High Density & Cohesion: Designed for high lifting power and structural support in deep layers of the skin.
Packaging
1 pre-filled syringe of 1 ml
2 sterile 27G ½" needles
Product label and detailed instructions
Indications & Application Areas
Indications:
Deep wrinkle correction
Structural and volumetric facial enhancement
Restoration of youthful contours and definition
Application Areas:
Cheeks: Restores lost volume and enhances midface contour
Nasolabial Folds: Fills deep lines between nose and mouth
Marionette Lines: Softens lines extending from the mouth to the chin
Jawline: Improves definition and structural symmetry
Clinical Benefits
Exceptional lifting and volumizing capacity
Smooth, cohesive texture for easy injection and natural results
High elasticity for long-lasting firmness and support
Advanced HY-BRID technology ensuring stability and safety
Comfortable treatment due to integrated Lidocaine
Treatment Protocol
Administration: To be performed exclusively by licensed medical professionals.
Injection Depth: Deep dermis to subcutaneous layer, depending on treatment area.
Technique: Linear threading or bolus injection for structural correction and volume restoration.
Duration: Results typically last 12–18 months, depending on individual metabolism and lifestyle factors.
Manufacturer & Regulatory Information
Manufactured by: Genoss Co., Ltd. (South Korea)
CE-marked Class III Medical Device under EU Regulation (MDR) 2017/745
ISO 13485 certified manufacturer
Distributed under compliance with AEMPS (Agencia Española de Medicamentos y Productos Sanitarios) in Spain and the European Union
For Professional Use Only
As trusted distributors and providers of aesthetic medicine, Aesthisave® emphasizes that our products are strictly for professional use.
We insist that these treatments be administered only by trained and medically qualified personnel, ensuring the highest standards of safety, precision, and patient care.
